Quick Answer
Cytek Biosciences, Inc. reported Net Income of $2.48 million for fiscal year 2022.
Cytek Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2022 | $2.48M | -17.9% |
| 2021 | $3.03M | -84.4% |
| 2020 | $19.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| June 30, 2023 | -$4.39M | -525.1% | +35.5% |
| March 31, 2023 | -$6.81M | -215.4% | -518.6% |
| September 30, 2022 | $1.63M | +14.5% | +331.6% |
| June 30, 2022 | -$702.0K | -126.3% | +67.5% |
| March 31, 2022 | -$2.16M | -2215.7% | -252.0% |
| September 30, 2021 | $1.42M | -78.3% | -46.8% |
| June 30, 2021 | $2.67M | -67.1% | +2517.6% |
| March 31, 2021 | $102.0K | +112.2% | -98.4% |
- Cytek Biosciences, Inc. showed a decrease of -17.9% in Net Income compared to the prior fiscal year.
- Over the 2020–2022 period, Cytek Biosciences, Inc.’s net income has declined by 87.2% (from $19.41 million to $2.48 million).
- The most recent figure is from Cytek Biosciences, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 1, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: